Results from the TIP (Tritace in Proteinuria) intensified monitoring project

Kidney and Blood Pressure Research

Volumn 25, Issue 2, 2002, Pages 80-86

  Mayer, G ^a  

^a UNIVERSITY HOSPITAL INNSBRUCK   (Austria)

Author keywords

Cardiovascular risk; Hypertension; Microalbuminuria; Proteinuria; Ramipril

Indexed keywords

CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; RAMIPRIL; GLYCOSYLATED HEMOGLOBIN; LIPID;

ADOLESCENT; ADULT; AGED; ARTICLE; BIOLOGICAL MONITORING; BODY MASS; CARDIOVASCULAR RISK; CLINICAL PRACTICE; CONTROLLED STUDY; DIAGNOSTIC VALUE; FEMALE; GENERAL PRACTITIONER; HEART FAILURE; HEART LEFT VENTRICLE HYPERTROPHY; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; MALE; MEAN ARTERIAL PRESSURE; MICROALBUMINURIA; NON INSULIN DEPENDENT DIABETES MELLITUS; PREVALENCE; PRIORITY JOURNAL; PROTEINURIA; REDUCTION; SMOKING; URINARY EXCRETION; ALBUMINURIA; AUSTRIA; BLOOD; BLOOD PRESSURE; CARDIOVASCULAR DISEASE; CLINICAL TRIAL; DRUG EFFECT; GLUCOSE BLOOD LEVEL; METABOLISM; MIDDLE AGED; MONITORING; RISK FACTOR;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ALBUMINURIA; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; AUSTRIA; BLOOD GLUCOSE; BLOOD PRESSURE; CARDIOVASCULAR DISEASES; CREATININE; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMAN; LIPIDS; MALE; MIDDLE AGE; MONITORING, PHYSIOLOGIC; PROTEINURIA; RAMIPRIL; RISK FACTORS; SUPPORT, NON-U.S. GOV'T; HUMANS; MIDDLE AGED;

EID: 0035988426     PISSN: 14204096     EISSN: None     Source Type: Journal    
DOI: 10.1159/000063512     Document Type: Article

References (34)

1. The sixth report of the joint national committee on prevention, detection, evaluation and treatment of high blood pressure
2. The prognostic significance of proteinuria: The framingham study
3. Randomized placebo-controlled trial of effect of ramipril on decline in glomerular filtration rate and risk of renal failure in proteinuric, non-diabetic renal disease
4. The effect of angiotensin-converting enzyme inhibition on diabetic nephropathy
5. Therapeutic efficacy of different antihypertensive drugs in human diabetic nephropathy: An updated meta-analysis
6. Renoprotective therapy: Titration against urinary protein excretion
7. Microalbuminuria as predictor of vascular disease in non-diabetic subjects
8. The association of microalbuminuria and mortality in non-insulin-dependent diabetes mellitus: A systematic overview of the literature
9. Microalbuminuria as predictor of increased mortality in elderly people
10. Proteinuria predicts stroke and other atherosclerotic vascular disease events in non-diabetic and non-insulin-dependent diabetic subjects
11. Prevalence and determinants of microalbuminuria in high-risk diabetic and non-diabetic patients in the heart outcomes prevention evaluation study
12. Is microalbuminuria a predictor of cardiovascular and renal disease in patients with essential hypertension?
13. Microalbuminuria is independently associated with ischemic electrocardiographic abnormalities in a large non-diabetic population: The prevend study
14. Micral test strips evaluated for screening of albuminuria
15. Microalbuminuria screening by reagent strip predicts cardiovascular risk in hypertension
16. Microalbuminuria and its relation to cardiovascular risk factors: A population-based study of 1,254 hypertensive individuals
17. Association between hyperlipidemia and microalbuminuria in essential hypertension
18. Is glomerulosclerosis a consequence of altered glomerular permeability to macromolecules?
19. Is microalbuminuria a marker of early intrarenal vascular dysfunction in essential hypertension?
20. Microalbuminuria reflects a generalized transvascular albumin leakiness in clinically healthy subjects
21. Effect of antihypertensive treatment on qualitative estimates of microalbuminuria
22. Treatment of patients with essential hypertension and microalbuminuria
23. Low-dose ramipril reduces microalbuminuria in type 1 diabetic patients without hypertension. Results of a randomized controlled trial
24. Effects of an angiotensin-converting enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients
25. Randomised controlled trial of dual blockade of renin-angiotensin system in patients with hypertension, microalbuminuria, and non-insulin-dependent diabetes: The candesartan and lisinopril microalbuminuria (CALM) study
26. Reduction of proteinuria by converting enzyme inhibition
27. Angiotensin-converting enzyme inhibition ameliorates glomerular filtration of macromolecules and water and lessens glomerular injury in the rat
28. Effects of angiotensin II receptor blockade on remnant glomerular permselectivity
29. Effect of converting enzyme inhibition on barrier function in diabetic glomerulopathy
30. Effect of low-dose enalapril on glomerular size selectivity in human diabetic nephropathy
31. Angiotensin-converting enzyme inhibition improves glomerular size selectivity in IgA nephropathy
32. Chronic proteinuric nephropathies. II. Outcomes and responses to treatment in a prospective cohort of 352 patients: Differences between women and men in relation to the ACE gene polymorphism
33. Smoking is related to albuminuria and abnormal renal function in non-diabetic persons
34. The Non-Insulin-Dependent diabetes, hypertension, microalbuminuria or proteinuria, cardiovascular events and ramipril (Diabhycar) study: Design, organization and patient recruitment